Antiglaucoma carbonic anhydrase inhibitors: a patent review

Article Properties
Cite
Masini, Emanuela, et al. “Antiglaucoma Carbonic Anhydrase Inhibitors: A Patent Review”. Expert Opinion on Therapeutic Patents, vol. 23, no. 6, 2013, pp. 705-16, https://doi.org/10.1517/13543776.2013.794788.
Masini, E., Carta, F., Scozzafava, A., & Supuran, C. T. (2013). Antiglaucoma carbonic anhydrase inhibitors: a patent review. Expert Opinion on Therapeutic Patents, 23(6), 705-716. https://doi.org/10.1517/13543776.2013.794788
Masini, Emanuela, Fabrizio Carta, Andrea Scozzafava, and Claudiu T Supuran. “Antiglaucoma Carbonic Anhydrase Inhibitors: A Patent Review”. Expert Opinion on Therapeutic Patents 23, no. 6 (2013): 705-16. https://doi.org/10.1517/13543776.2013.794788.
Masini E, Carta F, Scozzafava A, Supuran CT. Antiglaucoma carbonic anhydrase inhibitors: a patent review. Expert Opinion on Therapeutic Patents. 2013;23(6):705-16.
Journal Categories
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
You May Also Like
Refrences
Title Journal Journal Categories Citations Publication Date
10.1016/S0039-6257(99)00110-1 Survey of Ophthalmology
  • Medicine: Medicine (General)
  • Medicine: Ophthalmology
 2000
A multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucoma Bioorganic & Medicinal Chemistry Letters
  • Medicine: Therapeutics. Pharmacology
  • Science: Chemistry: Organic chemistry
  • Science: Chemistry: Analytical chemistry
  • Science: Chemistry
 14 2013
1α,25-Dihydroxyvitamin D3 and its analog, 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 (2MD), suppress intraocular pressure in non-human primates Archives of Biochemistry and Biophysics
  • Science: Biology (General)
  • Science: Biology (General)
  • Science: Physics
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 35 2012
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms? Chemical Reviews
  • Science: Chemistry: General. Including alchemy
  • Science: Chemistry
 930 2012
Dithiocarbamates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Action in Vivo Journal of Medicinal Chemistry
  • Medicine: Therapeutics. Pharmacology
  • Science: Chemistry: Analytical chemistry
  • Science: Chemistry
 183 2012
Citations
Title Journal Journal Categories Citations Publication Date
Commikuanoid D: A New Potent Carbonic Anhydrase-II Inhibitor from the Resin of Commiphora kua Chemistry of Natural Compounds
  • Medicine: Therapeutics. Pharmacology
  • Science: Chemistry: Organic chemistry
  • Technology: Chemical technology: Polymers and polymer manufacture
  • Science: Chemistry
 2024
Novel 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide based thiosemicarbazides as potent and selective inhibitors of tumor-associated human carbonic anhydrase IX and XII: Synthesis, cytotoxicity, and molecular modelling studies Bioorganic Chemistry
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry
  • Science: Chemistry: Analytical chemistry
  • Technology: Chemical technology: Polymers and polymer manufacture
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 2024
Overview of processed excipients in ocular drug delivery: Opportunities so far and bottlenecks Heliyon 2024
Design, synthesis and biological evaluation of novel ketone derivatives containing benzimidazole and 1,3,4-triazole as CA inhibitors Journal of Molecular Structure
  • Science: Chemistry: Physical and theoretical chemistry
  • Science: Chemistry: Physical and theoretical chemistry
  • Science: Chemistry
 1 2024
Isosteviol – A new scaffold for the synthesis of carbonic anhydrase II inhibitors Results in Chemistry
  • Science: Chemistry: General. Including alchemy
 2024
Citations Analysis
Category Category Repetition
Medicine: Therapeutics. Pharmacology167
Science: Biology (General)134
Science: Chemistry117
Science: Chemistry: Analytical chemistry96
Science: Chemistry: Organic chemistry81
Science: Chemistry: Organic chemistry: Biochemistry74
Medicine: Public aspects of medicine: Toxicology. Poisons38
Science: Chemistry: General. Including alchemy26
Technology: Chemical technology: Polymers and polymer manufacture24
Medicine: Medicine (General)8
Science: Microbiology7
Science: Chemistry: Physical and theoretical chemistry6
Science: Physics4
Medicine: Ophthalmology4
Technology: Chemical technology: Biotechnology3
Technology: Chemical technology2
Science: Chemistry: Inorganic chemistry2
Science: Physics: Nuclear and particle physics. Atomic energy. Radioactivity2
Medicine2
Agriculture: Plant culture2
Agriculture: Animal culture2
Science: Botany: Plant ecology2
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system2
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry2
Technology: Engineering (General). Civil engineering (General)1
Technology: Technology (General): Industrial engineering. Management engineering1
Technology: Electrical engineering. Electronics. Nuclear engineering: Materials of engineering and construction. Mechanics of materials1
Science: Physics: Atomic physics. Constitution and properties of matter1
Technology: Chemical technology: Food processing and manufacture1
Science: Mathematics: Instruments and machines: Electronic computers. Computer science1
Science: Biology (General): Cytology1
Medicine: Internal medicine1
Science: Biology (General): Genetics1
Medicine: Medicine (General): Medical technology1
The category Medicine: Therapeutics. Pharmacology 167 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Label-free characterization of carbonic anhydrase-novel inhibitor interactions using surface plasmon resonance, isothermal titration calorimetry and fluorescence-based thermal shift assays and was published in 2013. The most recent citation comes from a 2024 study titled CRISPR-Cas9-mediated deletion of carbonic anhydrase 2 in the ciliary body to treat glaucoma. This article reached its peak citation in 2018, with 35 citations. It has been cited in 70 different journals, 18% of which are open access. Among related journals, the Journal of Enzyme Inhibition and Medicinal Chemistry cited this research the most, with 50 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year